Free Trial

Oramed Pharmaceuticals (ORMP) Insider Trading & Ownership

Oramed Pharmaceuticals logo
$2.32
-0.06 (-2.52%)
(As of 11/1/2024 ET)

Oramed Pharmaceuticals (NASDAQ:ORMP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.70%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$293,240.00
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$261,328.75
Get ORMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ORMP Insider Buying and Selling by Quarter

Oramed Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/16/2023Nadav KidronCEOBuy26,000$2.04$53,040.00  
3/14/2023Nadav KidronCEOBuy100,000$2.01$201,000.00  
3/13/2023Yadin RozovDirectorBuy20,000$1.96$39,200.00  
1/3/2023Michael RabinowitzInsiderSell13,325$12.55$167,228.75  
3/21/2022Kevin RakinDirectorSell10,000$9.41$94,100.00  
(Data available from 1/1/2013 forward)

ORMP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oramed Pharmaceuticals includes Kevin Rakin, Michael Rabinowitz, Nadav Kidron, and Yadin Rozov. Learn more on insiders at ORMP.

13.70% of Oramed Pharmaceuticals stock is owned by insiders. Learn more on ORMP's insider holdings.

The following insiders have purchased ORMP shares in the last 24 months: Nadav Kidron ($254,040.00), and Yadin Rozov ($39,200.00).

Insiders have purchased a total of 146,000 ORMP shares in the last 24 months for a total of $293,240.00 bought.

The following insider sold ORMP shares in the last 24 months: Michael Rabinowitz ($167,228.75).

Insiders have sold a total of 13,325 Oramed Pharmaceuticals shares in the last 24 months for a total of $167,228.75 sold.

Oramed Pharmaceuticals Key Executives



This page (NASDAQ:ORMP) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners